. Correction to: Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy by Vannucchi, et al. Thyroid 2021;31(5):821-828; doi: 10.1089/thy.2020.0269. Thyroid 2022 Apr 25. doi: 10.1089/thy.2020.0269.
PMID: 35467967